BioSpace News Archive

Policy

J&J Will Appeal $8 Billion Verdict of Claims Risperdal Caused Breast Growth

The jury found the company failed to warn patients of a side effect causing young men who used the drug to grow breasts (gynecomastia).

October 9, 2019
·
3 min read
·
Alex Keown
Business

Industry Champion Jim Greenwood to Retire Following 2020 Elections

During his 14-year tenure as head of BIO, Greenwood oversaw a significant growth at the organization, more than tripling its size to 176 employees with an 85 million operating budget.

October 9, 2019
·
4 min read
·
Alex Keown
Policy

FDA Boosts Rare Disease Research with $15 Million in Grants

The grants were awarded through the FDA’s Orphan Products Clinical Trials Grants Program that was provided by Congress to specifically encourage the development of treatments for rare diseases.

October 9, 2019
·
3 min read
·
Alex Keown
BioSpace Global Roundup, Oct. 10

Companies from across the globe provide updates on their business and pipelines.

October 9, 2019
·
5 min read
·
Alex Keown
Business

Avid Bioservices Announces Completion Of Expansion Of Process Development Capabilities And Laboratory Infrastructure

Company to Host Open House to Celebrate Official Launch of Newly Expanded Laboratories

October 9, 2019
·
2 min read
Lucence Diagnostics and Tan Tock Seng Hospital Collaborate on Decision Support Tool to Reduce Risks of Liver Cancer Surgery

Tan Tock Seng Hospital and Lucence are developing a next generation decision support tool for liver cancer patients, which aims to reduce the risks associated with liver cancer surgery.

October 9, 2019
·
4 min read
GE Healthcare and Theragnostics announce global commercial partnership for late stage PSMA diagnostic for prostate cancer

GE Healthcare and Theragnostics have entered into a global commercial partnership for a new Prostate-Specific Membrane Antigen (PSMA) PET/CT imaging agent.

October 9, 2019
·
3 min read
Helsinn to co-host alongside Recordati Rare Diseases satellite symposium on MF-CTCL diagnosis optimization at European Academy of Dermatology and Venereology Congress 2019

Helsinn announces it will be co-hosting alongside Recordati Rare Diseases, a worldwide leader in rare diseases and orphan drugs, part of Recordati Group, a satellite symposium at the 28th European Academy of Dermatology and Venereology Congress, held this year in Madrid from 9 – 13 October 2019.

October 9, 2019
·
6 min read
Genetown

Rentschler Biopharma is once again featured on Germany’s top-ranked employers list

Rentschler Biopharma SE, a world-class contract development and manufacturing organization for biopharmaceuticals, has been featured on the annual list of Germany’s best employers for the second year in a row.

October 9, 2019
·
4 min read
Business

N-SIDE welcomes Wade Wirta as US Managing Director

N-SIDE, a global software consulting company specializing in advanced analytics technologies, is pleased to welcome Wade Wirta as US Managing Director.

October 9, 2019
·
2 min read